FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

IntegraDose Compounding Services ceFAZolin Recall

ceFAZolin, 2 G/20 mL in Sterile Water, 20 mL Sterile Syringe for Injection, IntegraDose…

IntegraDose Compounding Services LLC · Minneapolis, MN

Risk level
Class II
Reported by FDA
Oct 6, 2021
Recall ID
D-0896-2021
Check your lot numberHow we source this data

Summary

IntegraDose Compounding Services recalled ceFAZolin starting Sep 17, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0896-2021 on Oct 6, 2021. Reason: Lack of sterility assurance. Status: Terminated.

Why it was recalled

Lack of sterility assurance.

Product description

ceFAZolin, 2 G/20 mL in Sterile Water, 20 mL Sterile Syringe for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-7087-1

Lot numbers, UPCs & expiration codes

Lot, expiry: Lot 20210803CEF-1, exp 09/17/2021; Lot 20210805CEF-3, 09/19/2021; Lots 20210806CEF-1, 20210806CEF-2, exp 09/20/2021; Lots 20210809CEF-1, 20210809CEF-2, exp 09/23/2021; Lot 20210810CEF-1, exp 09/24/2021; Lot 20210811CEF-1, exp 09/25/2021; Lot 20210812CEF-1, exp 09/26/2021

Where it was sold

NH, MA, MN

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0896-2021
Classification
Class II
Status
Terminated
Recall initiated
Sep 17, 2021
FDA report date
Oct 6, 2021
Quantity
2,614 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
IntegraDose Compounding Services LLC

Original FDA data

Every field from FDA enforcement report D-0896-2021, exactly as published.

Show all FDA fields
City
Minneapolis
State
MN
Status
Terminated
Country
United States
Event ID
88731
Address
719 Kasota Ave Se
Code information
Lot, expiry: Lot 20210803CEF-1, exp 09/17/2021; Lot 20210805CEF-3, 09/19/2021; Lots 20210806CEF-1, 20210806CEF-2, exp 09/20/2021; Lots 20210809CEF-1, 20210809CEF-2, exp 09/23/2021; Lot 20210810CEF-1, exp 09/24/2021; Lot 20210811CEF-1, exp 09/25/2021; Lot 20210812CEF-1, exp 09/26/2021
Postal code
55414-2842
Report date
Oct 6, 2021
Product type
Drugs
Recall number
D-0896-2021
Classification
Class II
Recalling firm
IntegraDose Compounding Services LLC
Product quantity
2,614 syringes
Termination date
Oct 2, 2022
Reason for recall
Lack of sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
ceFAZolin, 2 G/20 mL in Sterile Water, 20 mL Sterile Syringe for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-7087-1
Distribution pattern
NH, MA, MN
Recall initiation date
Sep 17, 2021
Initial firm notification
Telephone
Center classification date
Sep 30, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0896-2021, published Oct 6, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls